EUVIMEDEUVIMED entdecken
FallberichtOpen Access

FGFR1/2/3 ‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract

Ying-Hsia Chu iD, Kerry Mullaney, Sara E DiNapoli, Marc A Cohen, Bin Xu iD, Ronald Ghossein, Nora Katabi, Snjezana Dogan iD

Histopathology · 2024

DOI: 10.1111/his.15099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Histopathology, 2024. Verfasst von Ying-Hsia Chu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Carcinoma, Squamous Cell, Paranasal Sinuses, Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Memorial Sloan-Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Oncogenic FGFR1/2/3 rearrangements are found in various cancers. Reported cases in head and neck (HN) are mainly squamous cell carcinomas (SCCs) with FGFR3 :: TACC3 fusions, a subset of which also harbour high‐risk human papillomavirus (HPV). However, the knowledge of the clinicopathological spectrum of FGFR ‐rearranged head and neck carcinomas (FHNC) is limited. Methods and results A retrospective MSK‐fusion clinical sequencing cohort 2016–23 was searched to identify malignant tumours in the HN region harbouring FGFR1/2/3 fusion. FHNC were characterised by histological examination, immunohistochemistry and molecular analysis. Electronic medical records were reviewed. Three FHNC were identified. Two cases (cases 1 and 2) involved sinonasal tract and were high‐grade carcinomas with squamous, basaloid, glandular and/or ductal–myoepithelial features. Case 1 arose in a 79‐year‐old man and harboured FGFR2 :: KIF1A fusion. Case 2 arose in a 58‐year‐old man, appeared as HPV‐related multiphenotypic sinonasal carcinoma (HMSC), and was positive for FGFR2 :: TACC2 fusion and concurrent high‐risk HPV, non‐type 16/18. Case 3 was FGFR3 :: TACC3 fusion‐positive keratinising SCCs arising in the parotid of a 60‐year‐old man. All three cases presented at stage T4. Clinical follow‐up was available in two cases; case 1 remained disease‐free for 41 months post‐treatment and case 3 died of disease 2 months after the diagnosis.

Conclusions

FHNC include a morphological spectrum of carcinomas with squamous features and may occur in different HN locations, such as parotid gland and the sinonasal tract. Sinonasal cases can harbour FGFR2 rearrangement with or without associated high‐risk HPV. Timely recognition of FHNC could help select patients potentially amenable to targeted therapy with FGFR inhibitors. Further studies are needed (1) to determine if FGFR2 rearranged/HPV‐positive sinonasal carcinomas are biologically distinct from HMSC, and (2) to elucidate the biological and clinical significance of FGFR2 rearrangement in the context of high‐risk HPV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsCarcinoma, Squamous CellParanasal SinusesParanasal Sinus NeoplasmsMaleHumansAgedMiddle AgedRetrospective StudiesMicrotubule-Associated ProteinsKinesinsReceptor, Fibroblast Growth Factor, Type 1

Stichwörter der Autor:innen

FGFR1FGFR2FGFR3RNA sequencinghead and neck squamous cell carcinomaparotidsinonasal carcinoma

Substanzen

TACC3 protein, humanMicrotubule-Associated ProteinsKIF1A protein, humanKinesinsFGFR1 protein, humanReceptor, Fibroblast Growth Factor, Type 1

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Ying-Hsia Chu, Bin Xu, Snjezana Dogan

Förderung

  • NCI NIH HHS
  • Memorial Sloan-Kettering Cancer Center

Zitieren

APA

Chu, Y. H., Mullaney, K., DiNapoli, S. E., Cohen, M. A., Xu, B., Ghossein, R., Katabi, N., & Dogan, S. (2024). FGFR1/2/3 ‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract. Histopathology. https://doi.org/10.1111/his.15099

Vancouver

Chu YH, Mullaney K, DiNapoli SE, Cohen MA, Xu B, Ghossein R, et al. FGFR1/2/3 ‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract. Histopathology. 2024. doi:10.1111/his.15099

BibTeX
@article{Chu2024,
  author = {Chu, Ying-Hsia and Mullaney, Kerry and DiNapoli, Sara E and Cohen, Marc A and Xu, Bin and Ghossein, Ronald and Katabi, Nora and Dogan, Snjezana},
  title = {FGFR1/2/3 ‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15099}
}
Kostenlos starten →